Nikhil Bhat

Nikhil Bhat is a pharmaceutical industry professional with extensive experience in commercial operations and data analytics. He served as Senior Director of Commercial Operations and Disease Education Team Lead at Global Blood Therapeutics from March 2019 to October 2022.1 In this role, he led the commercialization of Oxbryta, a first-in-class product for treating Sickle Cell Disease.1

Career Highlights

• Current Position: Principal at Blue Matter (July 2023 - Present)1
• Previous Roles:
  • Senior Director at Pfizer (October 2022 - July 2023)
  • Senior Director at Global Blood Therapeutics (March 2019 - October 2022)
  • Associate Director, Business Analytics at Gilead Sciences (July 2013 - March 2019)

Education

• MBA in Marketing and Strategy from University of California, Berkeley, Haas School of Business
• Bachelor of Technology in Information Technology from National Institute of Technology Karnataka1

Nikhil is known for his expertise in pharmaceutical data analytics and management, with a focus on using data-driven approaches to inform commercial strategy and operations.1